Comparative Efficacy and Safety of Three Janus Kinase Inhibitors in Ulcerative Colitis: A Real‐World Multicentre Study in Japan

Akiyama, Shintaro; Shimizu, Hiromichi; Tamura, Akiko; Yokoyama, Kaoru; Sakurai, Toshiyuki; Kobayashi, Mariko; Eizuka, Makoto; Yanai, Shunichi; Nomura, Kei; Shibuya, Tomoyoshi; Takahara, Masahiro; Hiraoka, Sakiko; Sako, Minako; Yoshida, Atsushi; Tsuruta, Kozo; Yoshioka, Shinichiro; Koroku, Miki; Omori, Teppei; Saruta, Masayuki; Matsumoto, Takayuki; Okamoto, Ryuichi; Tsuchiya, Kiichiro; Fujii, Toshimitsu

doi:10.1111/apt.18406

Public

Comparative Efficacy and Safety of Three Janus Kinase Inhibitors in Ulcerative Colitis: A Real‐World Multicentre Study in Japan

Published in Alimentary Pharmacology & Therapeutics • Nov 22, 2024

Authors:

Shintaro Akiyama

Hiromichi Shimizu

Akiko Tamura

Abstract

BACKGROUND: Three Janus kinase (JAK) inhibitors are approved for ulcerative colitis (UC) in Japan. AIM: To compare the real-world efficacy and safety of these three JAK inhibitors in UC. METHODS: This was a multicentre, retrospective study of patients with UC started on JAK inhibitors. The primary o...

Subject

Tofacitinib

Medicine

Ulcerative colitis

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!